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CHAPTER I 
INTRODUCTION 
Although it was not generally recognized until several years after-
ward, the flourish of activity which followed Becquerel's discovery of 
radioactivity was accompanied by a hazard of internally deposited radio-
activity equal to or of even greater importance than the external hazard 
of X-rays which was vagaely realized at the tille. Either hazard was 
I , , . 
relatively small considering the population as a whole because of the 
insignificant nWlber of people directly inTolved, However, since those 
times we have progressed through a period of limited though significant 
publio utilization or availability to the present higher level of public 
utili.za.tion a.nd exposure, This trend has followed the development of 
a.tdmic energy from a laboratory phenomenon to a technique ooDUllonly used 
in education, government, aed.icine, and industr1. Public involvement 
will most certainly accelerate with the installation of br~eder type 
power reactors in\po~ated areas because of the increased necessity for 
transcontinental or transworld shipments of irradiated tu.el elements to 
plutonium extraction facilities. This point is illustrated by the 
following discussion, 
The great practical importance of plutonium lies in its ability to 
undergo induced fission due to the absorption of neutrons and. its 
ability to release a great a.mount of energy during the process. 
The repeated use of plutonium, produced in a thermal reactor for 
2 
enriching fuel for the Sa.Jlle reactor, permits a marked improvement in 
the use of natural uranium. Estimates indicate that the utilization of 
plutonium reduces the consumption of natural uranium to a level that 
seems feasible in light of the present data and estimates of uranium 
resources, The concise analysis of the present and future energy con-
sumption in the world indicates a vital role for plutonium, Until 
large scale thermonuclear power stations are oommissiened, the predom-
inant role in the extension of the power industry will bit played by 
U-238 or actually by plutonium which is produced from that isotope, 
Taking as 100 the initial load of plutonium into the fast reactor, 
20 parts of the plutonium are fissioned after ene full cycles at the 
same time 30 new parts of plutonium are formed, Thus after 10 fuel 
cycles an amount of plutonium equal to the initial load in the reactor 
is obtained, Plutonium is a fuel of greatest importana~ as far as the 
breeding process is concerned because of the relatively short time 
~ 
required for this doubling of the amount of fuel (approximately siX' 
years), It is evident, however, that the plutonium must be returned to 
the reactor several times before it can be completely utilized, 
Many of the most colllll'lon internally deposited fission products are 
handled routinely thro~gh whole body monitors. These products generally 
tend·toemit X or gamma rays of 100 KeV or greater energy with relatively 
high yields, both of which make penetration of the human anatomy and 
detection fairly efficient, The isotope of particular importance here, 
Pu-239, unfortunately emits electromagnetic radiations of low energies 
and with relatively low yields, The production of U-235 through alpha 
decay of the Pu-239 of intensities 20, 70, 5,5, 2,5, and 1,; quanta per 
million alpha transitions and by X-rays ef 13,6, 17.40 and 20,5 KeV of 
intensities 1.2, l.J, and o.J x 10-2 quanta. per decay. 
As for the ha.rlllful effeets of alpha. emitting eleaents accW11.ulated 
in the body, medicine has had the greatest experience with radium.. 
During the past 60 years there have been cases of radium poisoning that 
often ended in death. The similarity between the physiological effects 
of radium and plutonium is due to the fact that both elements accumulate 
in bones in the form of insoluble phosphates, both emit alpha particles, 
and they have half lives differing only by one order of magnitude 
(radium--1.540 years, plutonium--24,J60 years). 
The harmful effects of both radium and plutenium are increased 
substantially by the concentration mechanism in the body. Plutonium is 
absorbed by the tissues and is carried by the blood stream into the 
bones where it is accumulated, The critical organ fer plutonium varies, 
however, depending upon the solubility of the material and upon the 
mode of intake. Bone is the only critical organ for inhaled, ingested, 
or injected plutonium in the soluble fora. The lung is the critical 
organ for inhaled plutonium in the insoluble form. The gastrointestinal 
tract--(GI tract) becomes the critical organ if insoluble plutonium is 
ingested. If the plutonium does eventually settle in the bone tissue 
and in the marrow cavity, the alpha. particles emitted attack the blood-
forming tissues directly. 
On the basis of the above observations, it has been accepted that 
if an alpha emitting isotope concentrates in the bones like radium does, 
its toxicity can be compared to that of radium. The m.a.xil'Jl.um permissible 
bttrdens f@r plutonima have been assessed by taking as a starting point 
comparable studies of toxicity of radiUlll and platoniUll iD the bodies of 
animals. From this research it has been found that plutonium is much 
4 
more toxic than radium. The ratio of toxioities varies from 10 to 30 
depending upon the duration of action on the body. In a.na.1.yzing the 
pa.st oases ef raait1111. poisoning, a maximum permissible body burden of 
0.1 pOi or 0.1 }lg of radio lla.s been established, The maxi.mu pen.is-
sible body burden of plutonium is now established a.t o.04 p.Ci (o.64 pg) 
which corresponds to approximately 1500 alpha disintegrations per second, 
Seme calculations demonstrate how small the corresponding quantities of 
plutonium permissible in the atmosphere a.re, The maxiJll.um permissible 
concentration in air is 2 x 10-12 uCi/cm3, that is 3.2 x 10-11 p.g/cm'J, 
which means that air containing plutonium at the maximum permissible 
concentration must not have more than one plutonium particle o'l C,l)Wll 
diameter per liter. 
. '.Ii 
·, l\ 
Because all of these limits a.re based on the dose-effect relation-
ship for irradiation of biologioa.l systems, one ef the prime consider-
ations in evaluating the potential hazards frem internally deposited 
radioisotopes is the bielegica.l. dose received by various organs, In 
such a determination the accurate estimation of the activity intake, A0 , 
is of para.mount importance, Since reconstruction of a.cute intake cir-
eumstances is not often pessible, the only alternative solution to the 
problem is the estimation of Ae after the fact by any aea.sttre available., 
The measures which a.re available would be better if it were not for 
the fact that each inhalation and victim is ph7siea.lly and physiologi-
cally different, Errors are induced in all forms of ceunting data by 
such physical differences. Bioa.ssay error is induced by physiological 
dif:ferenoes. What is needed, therefore, is a set of da.ta correction 
factors involving these physical and physiological variables. The raw 
counting or bioassay data could then be treated with these facters to 
5 
yield u accua.te estimate of J.e • .Attempts are presently being made to 
' 
achieve this geal, but possible results are limited beeau.se ef the re-
strictioa of related research to laboratory an1ma.la er to bu.man phaatom 
studies. 
In 1967 ia.m.sden and Davis analyzed the calibration errors which 
exist in phantom-related work and subsequently proposed experiments to 
minimize these errers. It was propesed at that time that a Yery limited 
number ef experiments be carried. eut t:tsing human volunteers inha.l.ing an 
aerosol of knewn activity, solubility, and particle size. Da.ta from the 
volunteers would be oelleoted over a definite period of time by enough 
independent means to indicate both levels arul trends cencerning aerosol 
retention, excretion, translecation, and dietribu.tion. 
It was decide4 at a much later date that the most efficient imple-
mentatien of these objectives would necessitate the orderly development 
alemg the following linesa (a) development, censtructien, a.11d testiDg 
of a suitable aerosol generating apparatus; (b) preductien and exten-
sive in.vesttSl\~ion of properties of a suitable aerosols (c) sequential 
inhalations by a single volunteer of aerosol tagged first with a soluble 
form ot a ga.Il111l8. emitting isotope and then with an insoluble form oft.he 
same isotope with subsequent compilation of data o:n the retention, excre-
tion, ed distribution ef the inhaled material; and. (cl) inhalatien.s by 
two volunteers of aerosol tagged with the insoluble form ef an isotepe 
which emits both X-rays in the 13-22 KeV region a.m.d gamma ra;rs in the 
100-400 KeV region using a one-deep-breath-and-held breathing pattern 
in one case ed shallow, eomtinueus breathing in the othe~ with the same 
data. being taken as in the previously mentioned inhalatiens. 
The experiments which will be discussed in this thesis a.re based 
6 
on the previously mentioned objectives. The first step (a) was achieved 
by constructing and testing an apparatus for producing insoluble 
spherical aerosol particles in the range 0,1 to 0.5)1lil. This method is 
extremely well suited to the ease when the available material for nebu-
lizing is limited and gives an overall recovery efficiency of 25%. The 
resultant particles are discrete, insoluble, and spherical but give a 
... , .... 
density which varies rapidly with particle size. The apparatus can be 
easily adjusted to give a high yield of particles of any chosen size in 
this range. The lower limit of particle size would appear to be of the 
order of O. 01 ;um. 
The method of generating insoluble iron oxide aerosols in the size 
range 0.1 to 0.5;wn, giving hollow particles of low density, can be 
applied to human volunteer inhalations while retaining the high effi-
ciency of aerosol production. The leaching characteristics of the tag-
. ;,t 
ging isotope, which depend critically on the particle size and the 
chemical form of the radioactive label, can be determined by in vitro 
studies. ~~e results of such inhalations give a consistent pattern of 
lung deposition and biological excretion, showing a high lung retention 
with a long, retained half period for a typical breathing pattern aimed 
at maximizing pulmonary deposition. Such deposition and retention 
curves can be corrected for the leaching characteristics of the tagged 
isotope and expressed in terms of retained aerosol when conditions of 
high leaching in~ exist. 
CHAPTER II 
HISTORY 
The history of plutonium is short in terms of years, but its role 
in the modern world is of great significance, The plutonium isotope 
Pu-238 was discovered in 1940 and this discovery was followed shortly 
by the discovery of the more easily fissioned isotope Pu-239, Utiliza-
tion of Pu-239 as a source of nuclear energy proceeded rapidly, and 0 
consequently, plutonium production soon became an important industry, 
Out of scientific and political necessity, early plutonium experimen~ 
tation and experience went through phases of biologically sterile in-
vestigations of physical and chemical properties to analytical methods 
and their applications, However, prior experience with radium poison= 
ing, which had occurred in radium watch dial painters and others who 
had received radium either occupationally or therapeutically, had re~ 
sulted in an awareness of biological hazards of exposure to radioactive 
materials in general, The post-war acceleration of free publication of 
plutonium data began to contain biological hazards in the early 1960•s, 
Injection Studies 
Extensive work of the Utah group and others (1, 2p 3) provided 
studies of intraperitoneally and intravenously administered soluble 
compounds of plutonium, Studies of the metabolism and toxicity of 
Pu-239 in small laboratory animals were initiated in an effort to assess 
,., 
8 
its potential role as an industrial hazard. The basic concept employed 
was to determine the relative toxicities of Pu-239 and Ra-226 in mice, 
rats, and rabbits; then to use this information, the knowledge of the 
effects of Ra-226 in man and the observed differences in human and 
rodent metabolism of the two radionuclides, to estimate the effects of 
Pu-239 in man, 
Although large numbers of animals had been used, as well as several 
criteria of toxicity, there, nevertheless, existed a great need for 
additional laboratory studies on animals which have longer lifespans 
than rodents and which have skeletons more like those of man, The 
reasons for this were as follows1 (a) Some of the principal effects 
observed in human radium poisoning are bone tumors, spontaneous bone 
fractures, carcinoma of the paranasal sinuses, and other more subtle 
skeletal changes, (b) Studies with Pu-239 in rodents indicated that it 
might produce bone tumors in man. (c) The times required for these 
effects to become manifest are about 15 to 20 years in man and the 
major portion of lifespan in rodents, (d) Since only adults would 
risk industrial exposure to Pu-239, knowledge was needed of its effects 
when deposited in a mature skeleton in contrast with a continuously 
growing rodent skeleton, 
Inhalation Studies 
Short term effects, following injection or inhalation, relating 
plutonium excretion, retention, tissue distribution, and dose were 
also found to be very important, The pioneering investigations of 
Scott, Abrams, and their co-workers (4, 5), which included work on 
plutonium fumes and smokes, were effective in pointing out the general 
9 
behavior of plutonium aerosols in biological systems. Studies by Bair 
and his co-workers (6), which are based primarily on insoluble forms of 
plutonium, are perhaps more pertinent presently. 
Using inhalation as the mode of administration and Beagle dogs as 
the experimental animal, Bair has produced a large traction of present 
knowledge concerning inhalation of insoluble aerosols. His experimental 
objectives have been to investigate the fate of plutonium taken into the 
body with inspired air. This information is required to evaluate the 
potential hazards of breathing air contaminated with plutonium and to 
aid in the establishment of permissible limits. Specifically required 
are knowledge of the fraction of plutonium inhaled that is deposited in 
the respiratory tract and the duration of its residency at the sites of 
deposition and in other tissues where plutonium is translocated. This 
information is helping to identify the tissues irradiated and to 
indicate the dose delivered, Knowledge of the relationship between body 
burden of plutonium and levels in blood and excreta are aiding in 
evaluating personnel exposures, because plutonium is not easily detected 
by external counting procedures. 
Similar experiments investigating the deposition and the fate of 
deposited plutonium as a function of particle size and of the total 
amount of plutonium deposited showed a marked effect of particle size 
on clearance, translocation, and excretion. Since comparisons of early 
animal results involved injection studies, experiments were completed to 
compare the behavior of inhaled and injected plutonium with the 
following resultss (a) For inhaled aerosols the pulmonary clearance 
process was found to be describable as a multiphasic exponential, (b) 
The bronchial lymph nodes and the lungs have the highest plutonium 
10 
concentration and on the average account for 95% of the body burden, 
(c) Few extrapulmonary tissues except the gonads and lymph nodes appear 
to receive important radiation doses. 
Human Studies 
Human data which are available have been collected primarily from 
accidentally exposed individuals, Langham (7) did conduct a Pu-239 
injection experiment using sixteen terminal human patients. This study 
still provides much of the most useful data on the subject, 
The most comprehensive compilation and analysis of animal and human 
data on inhaled aerosols is the Task Group on Lung Dynamics publication 
(8), With the ultimate objective of translating all available data into 
useful and applicable concepts, this group has provided a great service 
which would not have been possible by any other means, The ready avail-
ability of this data with the relevant conclusions and models has made 
it possible to standardize related research results which :may be human, 
phantom, or laboratory-animal based (9, 10), 
It is obvious, however, that much remains to be done before pluto-
nium inhalation severity can be accurately assessed through the extra-
polation of animal data, through bioassay data, or through phantom-
calibrated whole body or lung monitor results, The limitation of the 
last alternative method is the absence of the necessary phantom cali-
bration to a human standard which should precede any human calibration 
to a phantom standard, Even though much progress has been ma.de on the 
design and fabrication of human phantoms many of the same problems that 
inhibit accuracy in animal data extrapolation also limit accuracy in 
phantom-to-human extrapolations, 
11 
Long involvement in this field of study led Dautrebande (11) to 
express his concern over the data available at that time, and to a 
large extent his statements are still true, He notices that many con-
flicting results had been published regarding the deposition of airborne 
particulates in the respiratory tract, Most of the studies, relating 
either the mass er number of particles deposited in the lungs, had pro-
duced exaggeratedly scattered results, i,e,, from 2.5% to 90% for mass 
and from 1.5% to .50% for the number deposited, Among the many factors 
which he says have contributed to this situation are the omission of 
consideration of such important inhalation aspects ass changes in 
particle size distribution with changing solute concentrations as 
solutions are dispersed with some nebulizers, breathing methods and 
conditions, the duration of the breathing pause at the peak of the 
inspiratory phase, and the respiratory frequency and depth. 
Equipment 
AB important as the above to the successful conclusion of an inhal-
ation experiment are the selection, operatio1, and reliability of the 
,, 
aerosol production equipment and detection methods far the deposited 
aerosol material, 
Atomizing devices commonly used in generating aerosols may be 
classified into three main types, The first is the air blast or aero-
dynamical atomizer in which compressed air or other gas is used at high 
velocity to break up liquid emerging from a nozzle, It is characteris-
tic of atomizers of this type that they give a very wide range of drop-
let size though in some cases this variation is reduced by trapping the 
larger droplets within the atomizer. 
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The second type depends on centrifugal action, the liquid being fed 
onto the center of a rotating disc, cone, or top and centrifuged off the 
edge. The spray is characterized by uniformity of the main droplet size 
in marked contrast to the heterogeneity of sprays produced by most other 
methods, 
Thirdly, there is the hydraulic or hydrodynamical type in which 
liquid is forced through a nozzle and breaks 1:1p into droplets. Here the 
disintegration depends more upon the physical properties of the liquid 
and the conditions of ejection from the nozzle than upon interaction 
between the liquid and the surrounding gas. Probably the most success-
ful hydraulic atomizer, and indeed. the only one which has application 
for fine atomization, is the swirl chamber atomizer used in agricultural 
spraying equipment, internal combustion engines, and gas turbines. The 
swirl is produced by leading the liquid tangentially into the challlber 
and allowing it to spray out through a central orifice of small diameter. 
Outside this classification, and very much less well-known, are 
two additional types which may be listed as special atomizers. These 
are the electrostatic atomizers which break up liquid by the action of 
electrostatic forces and the acoustic atomizer which utlizes high 
intensity sonic or ultrasonic vibrations. It is such an ultrasonic 
device which is used to produce all of the particles which will be used 
in this :project, The prototype of this type of nebulizer was first 
described in 1927, 
A vast number of different materials have been used as the primary 
constituent of aerosol particles, These include everything from India 
ink to human serwn albumin and polystyrene to iron oxide (12, 13). Iron 
oxide was selected as the aerosol material to be used in this project. 
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Detection of the radioactively labelled aerosol particles once they 
are deposited in the lung can be based on whole or partial body counting 
techniques or on excretion studies or occasionally on examinations of 
tissues or tissue fluid samples. Whole body radioactivity monitors vary 
considerably in design, but all are proposed for the assessment of low 
level radioactive body burdens in man (14). In a majority of cases 
these monitors consist of a steel room acting as a radiation shield, a 
very sensitive detector system, and a subject support that provides a 
constant monitoring geometry. Whole body monitor measurements are 
adequate to detect incorporated activities at or below permissible levels 
for a very substantial number of nuclides, whether the levels taken are 
those that apply for single intakes or for a continuing intake at a 
constant rate. Partial body or local counting of the activity of a 
particular area of the body gives not only the extent of internal con-
tamination but can also indicate isotope location and distribution, 
Measurements of the excretion rate of radionuclides in the urine or 
feces are generally profitable for nuclides of which the permissible 
retained activities are low or the radiations are weakly penetrating. 
These advantages are achieved because of the removal of the absorbing 
medium and of the activity concentration steps which are the outstanding 
characteristics of all bioassay procedures. 
It was the evaluation, in terms of the equipment and methods de-
scribed, of various omissions of previous inhalation work as they apply 
to operational health physics which led to the establishment of the 
experiment objectives which will be discussed in the next chapter. 
CHAPTER III 
PROJECT OBJECTIVES 
Since the early days of the radiation era, it has been recognized 
that maximum benefits could be derived from ionizing radiation uses only 
if the individuals directly involved were physically and psychologically 
safe in their occupational pursuits. Practical and experimental deter-
minations of what practices are or are not safe usually result in the 
establishment of standards or limits which are designed to effect both 
individuals and their tasks in such a way that neither will~ predicted 
to suffer adverse consequences in the light of present experience and 
knowledge. In order to have the maximum effect, however, these limits 
must be accurately appraisable with presently available instrumentation, 
personnel, and techniques. Unfortunately, the evaluation of,,,Pu-239 
internal deposition, limited by the Maximum Permissible Body Burden, 
involves several intrinsic variables which tend to eliminate it from 
the limit group of maximum effect. 
Because all limits in radiation dosimetry are based on the dose-
effect relationship for irradiation of biological systems, one of the 
prime considerations in evaluating the potential hazards from internally 
deposited radioisotopes is the biological dose received by various 
organs. From the equation 
A f A t n! = 51.1 ~ o WM) ~EF (RBE)n x (1-e- eff ) 
eff 
" I, 
1.5 
t 
where D0 is the dose equivalent in rem received by an organ from time 
t • 0 tot following an acute intake, A is the activity of nuclide 
0 
deposited in microeuries, fw is the fraction of the nuclide deposited 
which reaches the organ of reference,,\ eff is the effective decay 
constant which considers both physical decay and biological elimination, 
M is the mass of the organ in grams, and~ EF (RBE)n is a constant 
related to the damaging effect per disintegration, it can be seen that 
the accurate determination 0f A0 is of paramount importance since it is 
the only variable that is not independently determinable, If A is not 
0 
t known, then D0 cannot be calculated, no comparisons to specified limits 
can be made, and no definite mode of corrective reaction, if necessary, 
can be formulated in behalf of the individual involved, 
Historically, the inhalation or ingestion eases were of the chronic 
intake variety. Evaluation of total intake from chronic exposure can be 
conveniently evaluated because the intake circumstances are usually well 
known and can be readily reconstructed if they do not still exist. More 
recently the major concern of internal dose evaluation units has been 
acute inhalation victims. In these circumstances A0 is the main unknown 
variable and usually accurate reconstruction is not possible, The only 
alternative solution to the problem is the estimation of A after the 
0 
fact by any measure available, Common techniques used for this lung 
burden estimation were discussed in the last chapter. 
These methods would be better if it were not for the fact that each 
inhalation and victim is physically and physiologically different, 
Errors are induced into all forms of eounting data by such physical 
differences. Bioassay error is induced by widely varying isotope solu-
bilities and by different individual excretion rates and patterns. What 
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is needed, therefore, is a set of data. correction factors involving ·\ · 
physical and physiological variables. The raw counting or bioassa7 data 
could then be treated with these factors to yield an accurate determina-
tion of A0 • Attempts are presently being made to achieve this goal, but 
possible results are limited because of the restriction of related 
research to laboratory animals or to human phantom studies. 
The first publication of work at the Atomic Energy Establishment, 
Winfrith, England, in this area was in 1962 (15). By 1967 several 
important contributions to the effort of detecting Pu-239 in vivo had 
been made by the group (16, 17, 18), In this year RuBden and Davis 
(19) analyzed the calibration errors which exist in phantom-related work 
and subsequently proposed experiments to minimize these errors, Even 
with the progress which had already been made they concluded that two 
:ma.in sources of error remained, the magnitudes of which were unknown but 
which might well be large, These were systematic errors in the chest 
phantom and errors stemming from the distribution of the contaminant 
throughout the chest. 
In the early stages of the work it became apparent that a large 
systematic error was caused b;y a gross mismatch of the soft tissue 
' ' thickness overlying the ribs between normal individuals and the chest 
phantom. Ultrasonic studies of the soft tissue thicknesses on the 
chests of a group of indiYiduals of widely varying body' build gave them 
confidence. in being able to predict a mean soft tissue thickness of any 
individual to within 2 mm, Without such a. correction any answers 
obtained by measuring the plutonium K X-rays would be in error by as 
muoh as a. factor of 4. It was found to be oonoeiva.ble thatLotber··sourees 
of systematic error also existed in the phantom. Among them were the 
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relative thickness of fat and muscle tissue in the ohest, the differ-
ences in soft tissue thickness beneath the rib oage, the rib thicknesses 
and relative spacings, and the size and shape of the lungs, The phantom 
was constructed to be a good match to a living subject at X-ray energies 
above 10 KeV. However, at best, it is only a simulation of a "standard 
man," and a series of cross calibrations between individuals and the 
phantom would be invaluable. 
Any variation in distributions was not allowed for in the phantom 
o~ibratiqns, which are based on an assumed homogeneous distribution of 
' 
activity throughout the lung. As the detection technique depends on 
counting soft X-rays(: 17 KeV) which are readily absorbed in soft 
' 
tissue (half thickness ::::: o.6 cm of soft tissue), slight changes in 
distribution throughout the chest region could produce large differences 
. 
in observed counting rates. It is known that the distribution of 
activity varies with time as large particles are rapidly cleared by 
ciliary action, and small ones are only slowly trapped in the lymphatic 
system. The distribution in any incident obviously depends on several 
~ factors, the following of which they hoped to study,in the proposed 
experimentsa (a) the spectrum of particle sizes inhaled, (b) the 
relative solubility of the particles in the chest and the ease of 
movement of the very small particles throughout the lung, (o) the physi-
ology and history of the individual involved. 
It was proposed at that time that a very limited number of experi-
ments be carried out using human volunteers inhaling an aerosol of known 
activity, solubility, and particle size. So lit.,.e is known of the dis-
tribution of activity in the lung following an inhalation incident that 
a considerable program of work could be started in this field by varying 
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some of the many parameters involved, such as particle sizer particle 
solubility, inhalation period, i,e,, one breath or oontinu.a.l. breathings 
and depth of breathing, 
_ Two basic experilllental approaches appeared to be possibles 
1, La.belling monodispersed aerosols of known particle size with 
easily identifiable gamma. emitting isotopes. The inhalation of such 
aerosols would enable the distribution of activity throughout the chest 
to be determined thus resolving the distribution problems discussed 
previously. 
2. La.belling the aerosol with isotopes that emit soft X-rays 
similar to those of Pu-239 (13.6, 17.0, 20,4 KeV), The volunteer sub-
jects would then be counted directly with the detectors developed for 
the estimation of Pu-239 in vivo. This approach would resolve the 
systematic errors present in the phantom but wo\tl.d give little indica-
tion of the distribution of activity in the chest due to tae absorption 
and scattering of the X-rays in body tissue. 
A combination of both approaches would be obtained if isotopes 
were used which emi tte_d both easily identifiable gamma. rays and suitable 
X-rays, 
At a. much later date it was decided that the most efficient imple-
mentation of these objectives would necessitate the orderly development 
along the following linesa 
l, Development, construction, and testing of a suitable aerosol 
generation apparatus. 
2. Production 8.llld extensive investigation of properties of a 
suitable aerosol. 
3. Sequential inhalations by a single volunteer of aerosol tagged 
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first with a soluble form of a gamma emitting isotope and then with an 
insoluble form of the same isotope with the subsequent compilation of 
data on the retention, excretion, and distribution of the inhaled 
material. 
4, Inhalations by two volunteers of aerosol tagged with the 
insoluble form of an isotope which emits both X-rays in the 13-22 KeV 
region and gamma rays in the 100-500 KeV region using a one-deep-breath-
and-hold breathing pattern in one case and shallow, continuous breath-
ing in the other with the same data being taken as in the previously 
mentioned inhalations. 
These specific topics will be dealt with individually and in 
detail in the following chapters. 
CHAPTER IV 
THE PRODUCTION OF EXPERIMENTALLY LABELLED 
AEROSOLS IN THE SUB-MICRON RANGE 
Studies of lung retention, sites of deposition, relocation and 
clearance following the inhalation of aerosols are in progress at 
several centers throughout the world (8, 20-23). As part of studies 
concerning the behavior of insoluble particles in the lung, with an aim 
to improving the ability to detect and estimate Pu-239 lung burdens in 
man. there is interest in producing insoluble particles in the size range 
0,05 to 0,5.,um and in tagging such particles with relatively short half 
lifennon-leachabl~1 radioactive label in order to study their behavior 
in vivo (24, 25). Of the labels being used, some are cyclotron produced 
and only available in small quantities [e.g. Pu-237 (tt 43 days}:/. 
Most of the aerosol generators and work reported in the literature 
produce particles in the size range 1 to 20).lm, and the generators have 
a low efficiency of nebulization, i.e., only a small fraction of the 
original material is finally available as aerosol, and of this only a 
small fraction is actually inhaled. In order to handle the limited 
quantities of materials available, an overall efficiency of about 20% 
I 
I from the initial isotope production on the cyclotron to the !inal 
I 
retained lung fraction was necessary with particles of the order of 
0.1)lm diameter and a fairly homogeneous size distribution • 
...," 
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Of the types of generator available, the ultrasonic nebulizer 
appeared the most promising. Particles produced by such a method show 
high porosity, and some trouble from the leaching of the radioactive 
label was expected (26). However, such a generator under the proper 
conditions will operate at high nebulizing efficiency. 
An aerosol production apparatus built around such a nebulizer 
was constructed and tested. Specifically designed to operate at high 
efficiency and low air volume, the apparatus is ideally suited for work 
with aerosol particles tagged with less readily available isotopes. To 
overcome the severe efficiency losses which accompany the often used 
nebulize-precipitate-dehydrate-suspend-renebulize sequence of stable 
aerosol production, the device inco~orates the particle dehydration 
essentials in the inlet air drying and preheating sections. 
Ba.sic Technique 
The aerosol particles are dehydrated ferric oxide (Fe2o3) and are 
produced by nebulizing an aqueous deionized iron sol which is prepared 
in a manner very similar to that of Albert and his co-workers l27), The 
sols are prepared from ferric chloride and ferric nitrate solutions, 
deionization being of the order of 9'.3% and iron concentrations varying 
up to a maxim.um of 1.5%. 
The addition of the radioactive label (tag) is done in the sol 
phase prior to nebulization. The efficiency of labelling and the 
stability of the tag both in :tl!.2, and ,!! vitro depend on the method of 
production of the sol, the chemical form of' the isotopic tag, and the 
pH value of the mixture. With optimum conditions a labelling efficiency 
of greater than 90% can be obtained for many isotopes without any dele-
22 
terious effects on either the sol or the subsequent aerosols. The sols 
prove to be very stable and can be stored for long periods both in the 
tagged or untagged state. 
Nebulization of the sol produces droplets which, when dry, give 
hollow spheres of dehydrated ferric oxide. The method of production 
and the particle characteristics are described below. 
Apparatus Construction 
The apparatue, shown schematically in Figure 1 and photographically 
in Figure 2, consists of an aerosol generation box and ~,storage>· 
reservoir. The four liter generation box is constructed in three 
sections of square cross section, each of which is detachable for de-
contamination and internal modification purposes. 
Section 1, the heating chamber, consists of a conventional light 
bulb and socket mounted in a square box of 1/16th inch aluminum, 
Section 2, the ultrasonic nebulizer, originally manufactured for 
use in the humidification of inspired gas for patients with tracheostomy 
or an endotracheal tube, is located at the base of the nebulizing 
chamber (28). In order to make the air movement as uniform as possible 
in this chamber, baffle plates are inserted between it and the heating 
chamber. The design of these baffles was empirical, most of the slots 
being at the sides and base of the plates, 
Section 3, the electrostatic precipitator, consists of four 
polished steel plates with staggered holes cut so as to ensure a maxi-
mum path length for the air stream without producing direct impingement 
onto the perspex container walls. In practice this precipitator was not 
required for its initial purp~se and serYed merely to provide a long 
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drying pa.th for the air stream to ensure complete drying of the original 
droplets, 
Both Sections 2 and 3 a.re constructed of 1/Bth inch perspex with 
gasketed flanges and conventional clamping. Pressure and temperature 
can be monitored at several points as can flow rates and volumes, 
Facilities are also available to extract samples of the aerosols at 
several points. This sampling is usually onto Millipore papers ( 0, 01 .,um), . 
The aerosol reservoir consists of at inch perspex cylinder, .6 in, 
diameter by 18 in~ long, containing an eight liter veter~ cattle 
anesthetic . bag which is attached to the main airstrea.m. line, The bag 
and the rest of the cylinder can be independently evacuated to enable 
pressure balancing to be done before inhalation, On Figure 1 the ma.in 
aerosol lines ( 1 inch copper) and vacuum or o.ontrol bypass lines ( t inch 
copper) are also shown, The arrangement of the bypass lines ensures 
that proper pressure, temperature, and flow rate conditions are estab-
lished before the aerosol is produced, The bag is initially evacuated 
and filled during nebulization, Pressure balancing is achieved by 
independently controlling the bypass lines into the perspex cylinder, 
Aerosol Production 
The filtered inlet air moves at approximately eight liters per 
minute into a silica gel drying tube, The dry air is then heated to 
about 4o0c in the heating challber by a 60-watt light bulb, The final 
stability of the particles is very dependent on the proper conditions 
being maintained in these two areas, i,e,, a controlled flow of warm, 
dry air. 
The sol is introduced into the nebulizer from a calibrated syringe 
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set into the roof of the nebulizer chamber (Section 2), The size of the 
droplets produced is primarily determined by the frequency and power of 
the crystal and is 3 ;Um for the particular 3 MHz crystal used, 
Dehydration of the droplets takes place mainly in_ the electrostatic 
precipitator (Section 3 of Figure 1). Testing of particles collected at 
point 61 of this figure shows that the particles are completely dehy- -
drated and stable in aqueous environments. 
From the dehydration chamber the aerosol is collected into the 
reservoir, Storage times of up to two hours in the bag have little 
effect on the particle recovery from the bag or on the size distribution, 
Inhalations are done directly from this bag via a normal anesthetic 
mouthpiece, The subject controls his own inhalation by means of mag-
netic valves, switching from normal laboratory air to the reservoir, 
The exhaled fraction is recollected in the bag which is externally moni-
tored by a scintillation detector, The bag is finally completely evac-
uated through Millipore filters. 
Efficiency of Nebulization 
Although efficiency is discussed in this section and particle size 
later in the chapter, it should be pointed out that the two are inter-
related, 
As mentioned above, the main objective was to obtain a high repro-
ducible overall efficiency. The tests of efficiency were done using 
radioactive labels f:"Fe-59 (tt 45 days), Cr-51 (tt 27 days).:/ and 
counting samples of the filtered aerosol from several points in the 
apparatus. Further tests showed that these samples consisted of dry, 
discrete, spherical particles of ferric oxide which could easily be 
27 
resuspended from the Millipore papers and studied under an electron 
microscope, A known initial activity was introduced into the nebulizing 
chamber as a small volume of labelled sol and all efficiencies obtained 
refer back to this initial activity as a percentage collected, Testing 
at the aerosol exit (Point SJ of Figure 1) showed no statistical differ-
enee in collection efficiency here and .. at Points S1 and S2. 
Nebulization efficiency was st~41ed as a function ofa (a) sol 
concentration, (b) flow rate, (c) collection time, (d) back washing, 
and (e) sol volume. The results are presented graphically in Figures 
J-6. 
The efficiency, as a function of sol concentration, is shown in 
Figure J with the 1 er confidence interval noted, Within the statistics 
shown, very little trend can be deducted from this graph. There is 
evidence of a broad maximum in efficiency of 25% with sol concentrations 
of about 0.1% iron by weight, ' Certainly at higher concentrations, 
giving larger particle sizes, increasing loss due to impaction may be 
expected, The drop in efficiency at lower concentrations (smaller 
particle size) is attributed to the apparatus design, 
Figure 4 shows the continuously improving efficiency with flow 
rate throughout the workable flow rate range (sol concentration was 
kept at 1.5% iron). 
Figure 5 shows the relationship between collection efficiency and 
collection time for a 1.5% iron sol being collected at eight liters per 
minute. All three graphs show that a mean efficiency of 25% is easily 
obtainable with usable flow oon4itions, A standard. flow rate of eight 
liters per minute at a reduced pressure of 2/3 of atmospheric and a 
collection time of one minute gives a stock aerosol volume which can be 
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inhaled in one or two breaths, 
Efficiency can be improved still further if an attempt is made to 
wash back some of the settling droplets and splashes which occur in the 
nebulizing chamber, The loss due to "splashing" (about 50%) from the 
crystal is a function of the initial volume of sol introduced, Large 
volumes of sol also increase the humidity beyond the capability of the 
heating and drying system, Figure 6 shows the increase in efficiency 
with reducing the sol volume, At these small volumes (0,1 ml) losses 
in the capillary syringe become important and if a small washing volume 
is introduced the efficiency oan be increased further, This step, how-
ever, tends to dilute the last stages of nebulization and produces an 
aerosol with a larger than normal proportion of small particles, 
Collection efficiencies are relatively independent of differential 
pressure or of air temperature once favorable dehydration conditions 
have been established, 
Particle Characteristics 
Examination of the physical characteristics and particle sizing 
were done using stereosean mierographs produced on a scanning electron 
microscope. Figure 7 shows that the particles have the desired spheri-
cal shape and are not aggregated, If complete dehydration is not 
achieved, an aggregate of platelets is seen; these are not stable in 
aqueous environments and revert back to the solution, 
Particle sizes taken from these miorographs exhibit a normal distri-
bution (Figure 8), the count median diameter (CMD) being a function of 
the iron concentration in the sol (Figure 9). Assuming that the final 
aerosol particle results from simple dehydration of the 3,um sol droplet 
JJ 
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produced by the nebulizer, the diameter should vary linearly with the 
cube root of the iron concentration. Because the rapid drying tech-
nique used gives hollow particles, the relevant diameter to use would 
be the aerodynamic diameter (AMD), Conversion from CMD to AMD requires 
knowledge of the particle density. Again because of the hollow nature 
of the particles, the particle density (iron oxide) will be less than 
~ 
the bulk density or iron oxide. ~, 
The iron oxide density of the particles was derived from the meas-
ured volume distribution of the particles (electron micrographs) and the 
known mass of iron oxide in the original 3 pm sol droplet. The results 
are plotted on Figure 10 showing that the observed density approaches 
the bulk density (3,5) at particle sizes greater than 0,55 µm but drops 
rapidly with particle size showing a minimum (and sudden change in den-
sity gradient) at a particle diameter of O.Jpm. This relationship was 
cheeked by determining particle iron oxide denisty by an alternative 
technique, The sol was now manufactured from Fe-59 labelled ferric 
chloride solution and the radioactive label used as a tag to determine 
iron oxide mass in a known volume of aerosol particles. The nUlllber of 
aerosol particles in this volume was determined by a calibrated Pollak 
Counter (29), The Pollak Counter determines particle number density by 
using the particles as condensation nuclei and measuring the light ex-
tinction resulting from the fog produced by adiabatic expansion of the 
sample volume in a saturated environment, The results of these density 
measurements a.re also plotted on Figure 10 and produce excellent agree-
ment with the densities obtained by the first method. 
Using the known density-CMD relationship, the aerodynamic diameters 
can be calculated and the data replotted as AMD against the cube root 
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o:f' iron concentration lFigure 11). A weighted least-squares-best-fit 
line is drawn. The intercept at zero diameter is not at zero concentra-
tion, with a basic sol particle size (micelle) of the order of 0.01Jlllll 
the minimUlll aeresol particle size obtainable by this method is of this 
order, correspending to a concentration of ;::::1.3 x 10-4 g/1 (i.e. c-3. 
5 x 10-2)/(27), 
Discussion 
The idea that the ferric oxide aerosol particles a.re hollow has 
been advanced (30). It is known that producing particles from atomizing 
solutions in volatile solvents may produce a spherical shell if the 
drying is rapid, and the remainder of the solvent is lost by evaporation 
after dif':f'usien through the shell. Any explanation of hollow;ae:rosoJ:,f · 
~9mposition,a.nd density must depend on the physical size of the primary 
sol particle, the mieelle, a spherical unit of about o •. 01,,um diameter 
and of density 3,5. 
The nebulized droplet, mean size 3 )Wll, will contain a number of 
micelles, the mean number being determined solely by the gross iron 
concentration of the sol. On evaporation of the water, the droplet 
reduces in size, the final size being determined by the geC>Jlletry of 
packing of the mioelle units in the sphere, 
The extension of this idea semi-empirically explains the shape of 
the density curve obtained experimentally. Several calculations can be 
.. 
initially made to formulate a sh~ model of the aerosol. If the unit 
micelle has a diaaeter 0.01,'Um, the number of micelles necessary to 
satisfy the ma.as requirements of each particle size A and the maximum 
number of micelles which can be acC&Dllllodated in each spherical shell of 
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defined diameter can be calculated. Then the minimum number of shells 
required to accomod.ate the required number of micelles per particle can 
be determined. 
Table I lists a few typical figures from such an argument using 
0,01.,um micelles, The total number required varies from 78 for a 0,1,.,um 
particle to 1.2 x 105 for a 0,51pm particle, 
The geometry of packing of the micelles in each shell unit is not 
known. Initially, packing determined by available surface area in each 
shell and the mean cross sectional area of a micelle was assumed. The 
maximum number per shell varies from 400 micelles in a shell of diameter 
0, 1 ,.um to 104 micelles in a shell of diameter 0,5 )llll, 
Three regions can be studied• 
1. Below 0,36pm diameter--single shell structure 
2. Above O, 51 pm diameter--mul tishell struoture--all shells filled, 
3. 0.36,um to 0,51 pm diam.eter--multishell struoture--some empty 
shells, 
Consider a hollow spherical aerosol particle of internal radius R1 
and external radius R ma.de up of basic spherical micelled units of dia-
o c 
meter D and bulk density p (the density of iron oxide) of 3,5, 
The mean density of the aerosol particle is then 
pF 5Ro r2 dr 
-
__ _..,,R,...1 ____ where F is a packing fraction constant (<1) p• (Ro 2 Jo r dr 
Consider the three regions. 'quoted· above I 
Region 1, Single shell structure R0 -R1• D 
p • pF ,L1-(1- ~ )'!J:: JiFD 
0 0 
(a) 
Shell Shell 
Dia. No, (p) N 
0,10 10 
0.11 11 
0,18 18 
0,23 23 
0.31 31 
0,;35 35 
0,37 37 
0,44 44 
0,48 48 
TABLE I 
TYPICAL VALUES OF PARAMETERS USED FOR "SHELL" MODEL 
--BASIC MICELLE SIZE 0,01 MICRON 
Shell Available Total 
surface locations locations iiA i are~ -per required (}lDl ) shell A 
31.4 x 10-3 4,00 x 10 2 . 1 7,80 x 10 4,00 x 102 10 
38.0 x 10-3 4.84 x 102 1,00 x 102 . 2 4,84 x 10 11 
10.2 x 10-2 1,30 x 103 1.98 x 102 1,-30 x 103 18 
16.6 x 10-2 2.12 x 103 - 2 3,90 x 10 2:12 x 103 23 
30,2 x 10-2 J,84 x 103 . 2 7,80 x 10 3,84 x 103 31 
38,5 x 10-2 4,90 x 103 3;90 x 103 4,90 x 103 35 
43,0 x 10 -2 .5,48 x 103 7,80 x 103 9,.57 x 103 35 
60,8 x 10-2 7,74 x 103 4 3.90 x 10 4 4,09 x 10 32 
72~4 x 10-2 9,22 x 103 4 7,80 x 10 4 7,82 x 10 8 
No, ef 
shells 
occupied 
< 1 
<. 1 
<. 1 
< 1 
< 1 
~ 1 
2 
7 
21 
Fraction 
of shells 
occupied 
q 
0,20 
0,16 
o. 11 
0,08 
0,06 
0,05 
0,10 
0.32 
0,88 
\ 
.c:-
..... 
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Region 2, All shells full R1 • o 
p • pF (definition of packing constant F) (b) 
Region 3, Some empty shells f:"If q is fraction of shells filled, 
i,e,, q = (R0 - R1)/Ro-l 
p • pF £1-(1-q)2 (c) 
From experimental observations, equation (a), Region 1 applied 
at R0 ~ 0,18 andp• 0,2, i,e,, FD• 0,00'.342pm. 
The observed maxilllum density in Region 2 is 3,2 and has also been 
observed by other workers (4), This gives a value of packing fraction, 
F, as 0,91 and the m1celle diameter D, as 0,0038 pm. 
A comparative plot of "theoretical" density and the experimental 
density cannot be made without assuming values for q in equation (c), 
Using a basic micelle diameter of 0,004 pm, Tabel II gives some values 
of derived values of q. Figure 12 then plots the comparisons between 
observed density (experimental points and the smooth curve derived from 
the above shell model). At particle diameters below 0,2 pm the experi-
mental densities lie below the curve, This discrepancy arises from 
ignoring the higher order terms in equation (a), 
This work does not disagree with the mean densities of iron oxide 
aerosol particles observed by other workers, The published data has 
been with particle diameters greater than 0,5 p.m when a mean density of 
3.2 is obtained, 
Experimental data on the leaching of radioactive label from 
particles both in vitro and in~ agree well with the above theory 
that leaching is a function of the exposed surface area of micelles, 
The degree of leaching observed experimentally varies with particle size 
Sheli Sheil 
Dia, No, 
(p) N 
0,094 23 
0.111 ?7 
0,180 44 
0.226 5~ 
0,312 7,6 
0,349 85 
O_~ 365 89 
o,439 107 
0.-476 116 
TABLE II 
TYPICAL VALUES OF PARAMETERS USED FOR "SHELL'' MODEL 
--BASIC MICELLE SIZE 0.004 MICRON 
Shell Available Total 
_,/i 
surface locations locations ·~~ i 
area per required 
(,wn-2-) shell A 
27.9 x 10-3 2.12 x 103 1.13 x 10 3 2.12 x 103 23 
38."5 x 10-3 2:92 x 103 . <3 1.43 x 10 2,92 x 103 27 
-2 10,2 x 10 · 7,75 x 103 2.86 x 103 7.75 x 103 44 
6 -2 1 .o x 10. 4 1.21 x 10 5,64 x 103 4 1.21 x io 55 
-2 30,5 x 10 .. 4 2,31 x 10 4 1,13 x 10 4 2.25 x io. 76 
-2 38,2 x 10.-- 4 2,89 x 10· 4 .5 .64 x 10, 5;65 x 104 83 
-2 41,8 x 10- .. 4 3,17 x 10 1,13 x 105 1.18 x 10? 83 
-2 6Q.5 x 10-- 4;58 ~ 10~ - 5 5,64 x 10· ' .5 .5,69 x tO· 7~ 
7L1.x.10 -2 4 5.-38 x-10 . . 6 1"1J ·X·10- 6 1.13·x·1Cl 4 
No, of Fraction 
shells of shells 
occupied occupied 
q 
1 0,083 
1 0.072 
1 o.04.5 
i 0!036 
1 0.026 
2 O,o47 
4 0!089 
.. 
_17 0.31 
-57 0.98 
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0·1 
when all other variables are kept ~onstant, For ~xample the relative 
leaching of Cr-51 from the particles is 1.2% at 0,51 p.m and 14% at 
0,1 Jllll, This ratio is 0,086, The ratio of total mieelle units to 
micelle units in the outer shell is 11,25 for the 0,51 pm particle and 
1,0 for the 0,1 pm particle, giving a relative available surface area 
ratio of 0,089 which agrees very well with the observed leaching char-
acteristics, 
CHAPTER V 
THE INHALATION OF INSOLUBLE IRON OXIDE PARTICLES 
IN THE SUB-MICRON RANGE PART I--
CHROMIUM-51 LABELLED AEROSOLS 
The previous chapter reported on the performance of a high effi-
ciency aerosol generation apparatus to produce insoluble ferric oxide 
particles in the size range 0,1 µm to 0,5 µm CMD (31), That chapter 
reported on the overall efficiency of the equipment, the size range 
distribution of the particles, and gave a simple semi-empirical theory 
of the mechanism of particle formation to explain the observec density-
size relationship, 
In this chapter inhalation of Cr-51 labelled aerosols by volun-
teer subjects, lung retention of the particles, magnitudes and modes of 
excretion from the body and the resistance of the radioactive label to 
leaching both in vivo and in vitro will be discussed, 
Chromium~51 was chosen as the radioactive label for the first 
series of inhalation studies because of the low absorbed dose to the 
lungs of the volunteers (less than 20 mrem), the simplicity of detec-
tion of its single 320 KeV gamma line in vivo, and its convenient 
half period of 27 days, The extension of these inhalation studies 
to Pu-237 provides valuable information regarding the detection and 
estimation of more hazardous materials in the human lung (e,g,, Pu-239 
and U-235), Prior to such work it was necessary to have a good under-
I.,; 
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standing of the behavior of the ferric oxide particles in the lungs 
following an inhalation, This information is provided by the Cr-51 
experiments both by in vivo detection and by excretion analysis, 
This work does not attempt to simulate any specific aerosol encoun-
tered in any specific operational health physics area, nor does it make 
any attempt to use normal breathing patterns, Both particle si3e and 
breathing pattern were selected so as to give a maximum retained frac-
tion in the lung, i,e,, to maximum pulmonary deposition rather than 
deposition in the upper respiratory tract or the nasopharynx, 
Preparation and Labelling of the Sol 
Deioni3ation levels of better than 90% were achieved by the use of 
semi-permeable membranes with both ferric chloride and ferric nitrate 
solutions, The final pH values of the sol were in the range 3,5 to 4,5, 
The stability of the sol and the efficiency of labelling both depend 
critically on the pH value, Labelling is relatively simple with sols 
of high iron concentrations (2% iron by weight) and large sol volumes 
(10 ml) but the limited availability of some of the other tagging 
isotopes (Pu-237) meant that it was desirable that all the available 
isotope was tagged to a sol whose parameters were those required for 
the inhalation, i,e,, a sol of volume 0,2 ml and of iron concentration 
0,001% by weight, Although such restrictions were not necessary for 
the Or-51 labelling, plenty of Cr-51 activity being available, the more 
restrictive techniques were developed and tested using this isotope, 
Carrier free Cr-51 calibrated solutions were adjusted in pH, taken down 
to dryness, washed to remove excess acid, and the small volume of sol 
added to controlled pH, Contact times of around two hours were 
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sufficient to get labelling efficiencies of the order of 80%, A range 
of labelled sols were also prepared for the in vitro leaching studies, 
Two types of Cr-51 labelled iron oxide sol were used for the inha-
lations, The first consisted of using the chromium in the form of a 
chromate normally readily soluble; this was termed as "leachable" 
chromium, The second sol was labelled with chromic chromium after 
reduction of the chromate with sulphur dioxide, This second sol was 
termed as "non-leachable" chromium, 
The Inhalations 
The same subject was used for both sets of inhalations in order to 
keep the biological variations to a minimum, Similarly, the same 
breathing pattern was used for both experiments, This pattern consisted 
of one deep breath of four liters which collapsed the reservoir bag, 
This breath was held for a period of 18-20 seconds and slowly released 
back into the bag, The reservoir was finally evacuated through 
Millepore filters, According to Brown (32) such a breathing technique 
should ensure maximum short-term retention in the lung (-100%). The 
location of deposition and long-term retention pattern is a function of 
particle size (8), To give maximum deposition in the pulmonary region 
of the respiratory traet, the particle size of 0,05 (AMD) was chosen, 
In Vivo Detection 
All measurements were done on the Winfrith Whole Body Monitor (15), 
Lung burdens were determined with one of 5 in. x 4 in, Na! (Tl) crys-
tals positioned beneath the chest. This crystal was calibrated using 
a realistic chest phantom developed for Pu-239 in y!!2, detection (18), 
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Total body Or-51 was determined by using a four-crystal array of static 
5 in, x 4 in, crystals in a oalibrated geometry, 
,, 
Crude location scans along the chest were done with a 3 in. x 5 in. 
crystal and a focused slit collimator (nine slits) of focal length 14 cm. 
These scans were done manually at three-inch intervals along the chest 
at varic,us dis~oes from the chest surface, 
All counte llfl,'e of 40 minutes duration, with the scan counts being \. . . 
of four minutes duration per position, The data was stored on punched 
paper tape for computer analysis. I· Prior to inhalation the subject•s 
normal body gamma spectrum was recorded. 
Bioassay 
- Both fecal and urine analyses were performed, Total collection of 
s(l.Dlples was achieved for the first four days after inhalation. The 
sampling period wa.s gra.~¥iY extended over a total period of ten weeks, 
The untreated urine samples were counted on a calibrated scintillation 
detector for Cr-51 activity while the fecal samples were wet-ashed and 
reduced to a standard volume prior to scintillation counting. 
Results 
The same volunteer was used for both inhalations, ,the time lapse 
between inhalations being four months. The particle size and breathing 
pattern wa.s the same for both the "leachable" chromiWll inhalation and 
the "non·leachable" chromium ~ation. The results are presented as 
comparing and contrasting the two types of,labelled aerosol inhalations, 
All retention and excretion curves were analyzed by the method of least 
squares to give a best-fit to a SWll of a series of exponential terms 
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and are presented graphically after correction for radioactive decay, 
Figure 13 shows the lung retention curves and are expressed as a 
percentage of the ini ti tal activity inhaled (""'" 1 ,,uCi), Both curves 
show a long-term retention component with a half period of 270 ± 20 days. 
In the case of the "non-leaohable" chromium this term predominates and 
has a magnitude of 82% of the initially inhaled material (showing that 
the aims of obtaining a maximum deposition of long-term retained aerosol 
had been achievedt, . The magnitude of the long-term component 1_ in the 
case of the "leaohable" chromium was 38%. Both curves show a short-term 
component representing the physical transfer of material from the naso-
pharynx and upper respiratory tract into the gut. These half periods of 
0.3 and o.6 days can be considered identical considering the errors in 
analysis at short time periods and the paucity of experimental data 
during the first day, This early clearance period has been studied 
fully by other workers(22). The magnitudes of this early clearance 
phase are very comparable at 21% (leachable) and 18% (non-leachable) 
showing that the breathing pattern and particle size were well matched 
in the two experiments, The "leachable" chromium also exhibited a 
third exponential term of half period 3 ± l days and magnitude 41%. 
This term is absent in the "non-leachable" material and represents the 
leaching of the chromium label from the retained iron oxide particles 
and transfer of the soluble chromate ion into the blood stream where 
it is complexed and excreted via the kidneys. 
The whole body retention curves are not shown here but are very 
similar to those of the lung, showing long-term retention components 
of '.300 "t 30 days and short-term clearances of O. 5 day half life. The 
third component in the "leaehable" chromium inhalation had a half period 
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of 6 t 1.5 days, The magnitudes of all these components, expressed as 
percentages, are very similar to those reported for the lung contents, 
and the whole body activity is initially some 20% higher than the lung 
activity, 
The lung retention curves can be compared directly with the fecal 
excretion curves (Figure 14) and the urinary excretion curves (Figure 
15), Both sets of excretion curves show a rapid clearance phase with 
half periods in the range 0,4 to 0.7 days, Again the errors in analy-
sis and paucity of early samples are such that no significance can be 
given to differences in these half periods, The magnitude of the early 
fecal clearance is roughly the same in both inhalations, peak clearance 
being observed at day 2 at approximately 25% of the inhaled material, 
These findings agree with the early lung clearance of 20% in the first 
day, the material being transferred to the gut and eventually excreted 
in feces, 
The urinary clearances differ by a factor of 10 between the two 
inhalations (Figure 15), The "non-leachable" chromium shows low uri-
nary detection to 0,04% per day, The "leachable" chromium shows a high 
early clearance component of 20% per day on day 1 and accounts for the 
"leached" chromium label seen in the lung retention curve, 
A longer term exponential is also seen in the fecal excretion of 
"non-leachable" material with a half period of 240 days and a magnitude 
of 0,1% per day of the initial lung activity. Although this long-term 
component is not seen in the fecal excretion of "leachable" materia1 0 
the excretion levels after day 8 are below the limits of detection of 
0,04% per day, and as such no analysis of this term was attempted, 
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Both urine excretion curves show evidence of a long-term component 0 
but again excretion levels are very close to the limits of detection, 
and no accurate assessments could be made, Approximately 1% of the 
initial intake is excreted per day as long-term urinary excretion of 
"leachable" chromium with a half period in excess of 100 days, The 
"non-leachable" long-term excretion is again a factor of 10 (0,1% per 
day) down on the "leachable" material, 
These results are discussed more fully later in the chapter and 
compared with the results obtained from in vitro leaching, but overall 
agreement in excretion patterns and retained fractions can be seen, 
This agreement can be expressed graphically by plotting the integrated 
excretion against time and comparing this to the drop in lung counts 
(Figure 16), In both cases accountability of better than 80% is 
achieved, 
The activities inhaled (---1 pCi) were not sufficient to enable 
accurate scans to be done over the chest region to obtain detailed 
information of the sites of deposition of the ferric oxide particles, 
The results from the manual scans using the collimated crystal over the 
chest are presented in Figure 17, Note the early clearance of the 
upper lungp the predominant deposition in the deep lung, and the 
increase in counts at the base of the lungs on days 2 and J as material 
passes down the esophagus to the gastrointestinal (GI) tract, 
The overall picture of deposition in deep lung agrees well with 
observed high long·-term retention in the lung (pulmonary deposition) 
and demonstrates the success of choice of particle size and breathing 
pattern, Comparison between the two inhalations shows that deposition 
was a little higher in the lung with the v•non-leachable" inhalation, 
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but the basic deposition patterns are very similar. The activity scales 
on Figure 17 are normalized to give equal deposition in the upper re-
spiratory tract on day 1. 
The relevant experiments for these chromium inhalations consisted 
of a suspension of tagged aerosol particles (0,0.5pm AMD) in isotonic 
saline solution. Two approaches were tried, Small samples were taken 
from a large-volume, closed system and analysed for chromium in the 
liquid (filtrate) phase and compared to retained chromium levels on the 
iron oxide, The second approach was to completely remove all chromate 
ions from the system via a semi-permeable membrane as they leached off 
the suspension of ferric oxide particles. This second system is not in 
equilibrium and is more typical of the situation as it occurs in the 
lung. The results from these experiments are presented graphically in 
Figure 18. 
Only two curves are shown in this figure: the first curve shows 
"non-leachable" material in a large-volume, closed system, giving a 
half period of leaching of 3.4 days and a maximum availability for 
leaching of 9%; the second curve shows "leachable" chromium in the semi-
permeable membrane system, giving a half period of leaching of 2.6 days 
and a maximum availability for leaching of 63%. Similar results were 
obtained for the other two conditions. 
Dose to Volunteer 
The amount of activity inhaled in each of the experiments was 
1 µCi Cr-51 (! 10%). Calculations utilizing observed lung retention 
patterns and using 1000 gas the mass of the lungs yield the following 
z ) 
I I ~-A~ ,:,-.-~· ,I I I 
(o)'NON LEACHAILE' Cr-51 t.0·20ld"1 (3.4 ....,,} 
I I 1 1 1 ~ .. ,9%. 
(b) 'LEAOIAlll.E ' Cr- SI k ,0·2b6d"1 { 2of1daJ1 ) 
A., abl :l4CJ'o 
D II 12 I I D 
ELAPSED TIME IN DAY~ -
Figure 18, Leaching of Cr-51 In Vitro 
59 
total absorbed doses to the volunteer's lungsa 
Inhalation 1 (leachable chromium) 
Inhalation 2 (non-leaehable chromium) 
Total to volunteer 
11 mrem 
21 mrem 
32 mrem 
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The recovery via urine and feces indicate that no long-term reten-
tion in blood (or liver or spleen) occurred, and the rapid transfer 
through the GI tract meant that doses to other organs are negligible 
compared to the lung dose, 
Discussion 
Viewed in the context of part of a thesis,,. the primary objectives of 
the chromium inhalations were to demonstrate that the overall high 
efficiency of aerosol production achieved by the nebulization apparatus 
could be maintained throughout the inhalation procedure and could give 
a high fraction of the particles retained in the lung with a long clear-
ance period (""-200 days). This high retention is achieved by choice of 
particle size and breathing pattern. It is this long-term retained 
fraction that is usually measured by in vivo detection techniques for 
more hazardous isotopes in the lung (e,g,, Pu-239 and U-235) and which 
contributes a high percentage of the absorbed dose to the lung from 
such isotopes. 
The early studies of the iron oxide particles produced, at the 
sizes required for these inhalations, showed them to be hollow spheres 
with a large surface area available for the leaching off of the isotopic 
tag, The density of these particles, 0,1 g/ml, is much less than the 
density of the larger particles used by other workers; above a diameter 
of 0,6fm a constant density of J,2 g/ml is obtained. Leaching of the 
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isotopic tag'., was, therefore, expected, and the chromium inhalation 
experiments were also aimed at measuring such effects, 
The use of the terminology "leachable" and "non-leachable" rather 
than the more ·usual terms--soluble (transportable) and insoluble (non-
transportable)--emphasize the fact that the phenomenon is one of 
removal of the isotopic label from the outer surfaces of the insoluble 
iron oxide particle rather than solubilization of the particle 
itself, This reasoning is confirmed in the animal experiments where 
Cr-51 labelled ferric (Fe-59) oxide particles are used and the Cr/Fe 
' 
ratio studied, 
The earlier chapter postulated that the aerosol particles were 
built up from discrete sol units (micelles) of diameter 0,004)lDl and 
that the relative leaching from particles of different sizes was a 
function of the surface area of the exposed micelles in the outer shell 
of the iron oxide particle, Such a postulation was confirmed experi-
mentally, At a particle size O,l;ttm (CMD) the shell model of particle 
structure would indicate that approximately .54% of the available inte-
grated micelle surface area was available for leaching, The in vitro 
leaching,data can be applied to the in vivo results to quantitatively 
correct for leached Cr-51 activity, 
The in vitro leaching results give a maximum of 6']%, available Cr-51 
from the "leachable" aerosol with a half period of the order of 3 't 0.5 
days, Comparison of this figure with the observed lung retention and 
urinary excretion patterns for the "leachable" inhalation shows a. com-
ponent of 2,9 days half period and 41% amplitude in the lung retention 
curve and a component of 47% (but only 0.75 days half period)in the 
urinary excretion curve. The mean of these two figures (44%) with the 
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allowance for the 21% of the initial activity which was rapidly cleared 
by fecal excretion, gives a mean percentage of available chromium in 
the in vivo leaching of 56% which compares well with the figures for in 
vitro leaching (63%) and that derived from the "mieelle" model (.54%). 
Applying similar arguments to the small amount of leaching seen with 
the "non-leaehable" material, the in vitro result is 9% compared with 
the in vivo result of 6,2% of available chromium, 
Such an approach explains the magnitude and period of the early 
urinary excretion but does not explain the fact that the "leachable" 
inhalation exhibits a long period urinary excretion term which is not 
seen in the case of the other inhalation, Assuming that the main long-
term clearance is via the eilliated escalator, the gut and fecal excre-
tion, long-term urinary excretion can be explained by postulating that 
the iron oxide particle, made up of an aggregation of smaller micelle 
units, becomes unstable in the acid environment of the stomach and any 
remaining chromium, in chromate form, is leached off at this stage and 
appears in urine rather than feces, Thus no long-term fecal excretion 
above the MDA is seen in the "leachable" inhalation and no long-term 
urinary excretion above the MDA is seen in the "non-leaehable" inhala-
tion, but the magnitudes and periods of the long-term urinary excretion 
for "leachable" material (0,8%/d..,. 100 days) is comparable with the long-
term fecal excretion of "non-leachable" material (0.1%/d, 240 days), 
In both inhalations the lung retention curves can be corrected for 
the removal of the radioactive label by leaching and expressed in terms 
of percentage of initial deposition of iron oxide particles, Such 
corrections can be made by assuming the urinary excretion represents 
excretion of chromium leached from the particles while in lung; this 
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would obviously be an overestimate of the effect, The alternative 
applied here was to correct the activity observed in the lung for the 
known leaching pattern as measured in vitro, Figure 19 shows the lung 
retention curves for both inhalations after suoh corrections based on 
the ~ vitro leaching curves shown in Figure 18, Because the inhala-
tions were done on the same volunteer subject with identical particle 
sizes and, as far as was possible, using identical breathing patterns, 
the retention of iron oxide particles in the lung should be the same 
when expressed as percentage of initially deposited aerosol. Figure 
19 shows that the corrected lung retention points from the two inhala-
tions are indistinguishable within experimental error and the line drawn 
is the best fit to both sets of points, 
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CHAPTER VI 
THE INHALATION OF INSOLUBLE IRON OXIDE PARTICLES 
IN THE SUB-MICRON RANGE PART II--
PLUTONIUM-237 LABELLED AEROSOLS 
The inhalation experiments consisted of two series; one using Cr-51 
labelled iron oxide particles was the subject of the previous chapter 
giving details of the isotopic labelling techniques, the inhalation 
apparatus, and in vivo detection equipment (33), That chapter reported 
on the studies of lung retention, location of the particles within the 
thorax region, fecal a~d urinary excretion, and in vivo and in vitro 
leaching studies, It gave a consistent picture of high lung retention 
( - 80%) with a long biological half period ( -300 days) in the pul-
• ' I 
monary region, The high retention figure was obtained by using small 
particles (0,05.,um AMD) and an atypical breathing pattern, 
This chapter reports on the final series of inhalation studies 
using aerosols labelled with Pu-237 and attempts to apply the results 
obtained to the field of the detection of more hazardous materials in 
the human lung, i,e,, Pu-239, 
Choice of Plutonium-237 
The problems of the detection of Pu-239 in the human lung and the 
interpretation of the results obtained have been studied in these 
laboratories and at other centers throughout the w.orld for several 
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years (34-37). In vivo studies on Pu-239 can only be made after acciden-
tal inhalations which are fortunately rare events, 
Whereas in the inhalation work reported earlier Cr-51 was picked 
as the labelling isotope because of the simplicity of its detection 
in vivo and the low absorbed doses to the lungs of volunteers, Pu..,.2~··1'!;\'' 
was picked because of its close match of low energy decays to Pu-239, 
i,e,, because of the difficulties of its detection in vivo, while main-
taining the low absorbed doses to the lung. 
Plutonium-239 decays by alpha emission, not detectable by monitor-
ing externally to the body, and by the emission of the L X-rays of 
uranium in approximately 4% of its disintegrations, the only gamma 
emissions having abundances of less than 0,01% per alpha. The L X-rays 
having energies of 13.6, 16,9, and 20,6 KeV can be detected, external 
to the chest, by means of specially designed low-background gas-filled 
detectors (34,35). The accuracy of such determinations of Pu-239 in 
the lung is critically dependent on the location of activity within the 
chest, i,e,, on particle size and breathing pattern, on the subjectus 
body gamma activities, on the subject's body build (obesitr), and on the 
isotopic composition of the plutonium contaminant (17, 38), Basically 
these difficulties all arise from the facts that the half thickness of 
the X-rays in soft tissue is small ( ,'"'\..-0,6 cm), scattered and degraded 
gamma radiations in this energy region are very dependent on body build, 
and the specific X-ray emission of the contaminant can vary by up to a 
factor of four depending on the irradiation history of the nuclear fuel, 
Many of these parameters have been studied by using realistic chest 
phantoms and by measuring the occasional inhalation incident (18, 25), 
Any simulator for Pu-239 must have abundant X-ray emissions of the 
correct energy and be of convenient half life to enable the longer-term 
retention fractions to be studied (i,e,, 10.-.50 ,day half period), Natur-
ally the absorbed dose to the lungs of the volunteer must be minimal, 
The simulator must also have higher energy gamma rays (100-.500 KeV) to 
enable accurate assessment of total lung activity and some location 
studies to be made by using conventional scintillation detection devices, 
Most Pu-239 contains a variable amoung of Am-241 which emits a 60 KeV 
gamma ray, The presence of a low abundance 60 KeV radiation from the 
simulator is an added advantage, 
In practice the choice of isotope satisfying the above requirements 
is limited, and only two were considered suitable. Pretaetinium-233 
had already been proposed and tested by other workers and Pu-237 had 
been used in animal work (39, 40), Table III compares the basic data 
for these two isotopes, 
TABLE III 
CHOICE OF SIMULATOR FOR PLUTONIUM-239 
Isotope Decay Half % L Gamm.as Daughters Production 
Mode Life X-rays 
{d.a;y:s} L ~ Z KeV Z 
Pa-233 Beta 27 38 44 310 U-233 Th-232 (n,¥~ 
Pu-237 E, C, 43 30 40 100 Np-237 U-23.5 (0< ,2n 
(.5) (60) 
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Protaotinium-233 has the great advantage of being readily available 
from neutron irradiation of Th-232 while Pu-237 is eyelotron produced, 
Plutonium-237 was finally chosen because of the presence of the 60 KeV 
radia.titlti.s'and the low absorbed tgse associated with•the capture decays, 
Production and Preparation of Plutonium-237 
Most owners of cyclotrons are understandably very reluctant to have 
enriched uranium targets in their machines because of the contamination 
resulting from any target failure, A cyclotron with an external beam 
facility and high current was needed for the Pu-237 production and the 
author is very grateful to the Hammersmith Medical Research Center, 
London, cyclotron unit for supplying irradiation time on their machine, 
In order to minimize direct production of Pu-236 ( ~ ,3n) and Pu-238 
(G\. ,n) a beam energy of 2.5,.5 MeV was selected and the target, manu-
factured from highly enriched uranium foil, welded onto an aluminum 
plate, Table lV summarizes the production details, 
TABLE IV 
PRODUCTION OF PLUTONIUM-237 
REACTION 
U-23.5 ( ~ ,2n) Pu-237 
COMPETING REACTIONS 
U-23.5 ( o<,o< ,n) Pu-238 
U-23.5 ( , 3n) Pu-236 
U-23.5 ( CX ,p2n) B 
U-23.5 ( o<. , d.n) Np-23622 hi Pu-236 
U-23.5 ( ~ , tl B 
U-23.5 ( "\ ,P Np-238 2 a} Pu-238 
U-23.5 ( OI.. , f 
BEAM ENERGY--2.5,.5 MeV He4 
IRRADIATION--80 µA hr 
TARGET--0,002"x1"x3" U-23.5 (93% 
enriched) foil 
YIELD--4 µCi Pu-237 
CHEMISTRY--rapid separation of 
Np, U, from Pu fraction 
IMPURITIES--less than o.o:3% total 
alpha (mainly Pu-236) 
After the initial chemical separation of the plutonium fraction by 
a series of ion exchange columns, final purification of the material and 
activity measurements could procede at a more leisurely pace, 
Aerosol Labelling and Production 
The aerosol of ferric oxide particles is produced by using an 
ultrasonic nebulizer to producemonodispersedroplets of a dilute ferric 
sol which are then dehydrated to the stable iron oxide, Labelling is 
done in the sol phase, Particle size is previously determined by the 
iron concentration in the sol phase and particle stability controlled 
by the production technique of a controlled flow of warm, clean, dry air1 
a dehydration chamber, and small volumes of sol (0,2 ml), Efficient 
labelling techniques depend primarily on the pH value of the sol and 
the chemical form of the isotopic label, Resistance to leaching off of 
the isotopic label both in vivo and in vitro depends on the chemical 
form of the label and the particle size, 
Because the activity available is limited, the techniques developed 
I 
required high efficiency of labelling in small volumes (0,2 ml) of 
dilute sol (0,01% Fe by weight) and an overall high efficiency of 
aerosol production ( ---- 20% from sol to final inhaled fraction). Both 
these aims were achieved and have been reported elsewhere. 
Inhalations 
Two volunteers were used for the two inhalations, each breathing 
in an atypical manner at the extremes of breathing pattern, Neither of 
the two patterns nor the particle sizes chosen were intended to repre-
sent any typical occupational exposure. Subject 1 inhaled an aerosol 
70 
of 0,1)lm (CMD) taking a deep breath of four liters and holding for 30 
seconds prior to slow exhalation. This technique should ensure maximum 
deposition in deep lung and was similar to that used in the Cr-51 inhala-
tions (32). Subject 2 inhaled an aerosol of 0,3µm (CMD) with shallow 
breathing of 250 mls/breath (minute volume 5 liters) ensuring deposition, 
if any, in the upper respiratory tract and nasopharyngal (NP) regions. 
In both cases the exhaled fractions were collected and assayed, About 
0,1)l.Ci Pu-237 was initially retained in the respiratory system for both 
volunteers. 
Measurements 
Measurements were taken below the chest with a large-area (5 in, 
diameter) thin Na.I crystal (2 mm thick) which was partially collimated, 
This crystal viewed both the 60 KeV and 100 KeV peaks, Above the chest 
one or two gas-filled proportional counters were used to detect the 17 
KeV X-radiations. These detectors, specifically designed for the detec-
tion of Pu-239 _!!!!!YQ., were used with various gas fillings to give a 
range of differing efficiencies of detection (41). 
Crude location scans were done on the 100 KeV line using a nine 
slit focused collimator on a 5 in, x 3 in, NaI crystal. The other detec-
tors, mentioned above, were also moved over and under the chest to give 
a range of responses and further information on the gross deposition of 
the aerosol in the chest. 
Initial calibrations were done with Pu-237 sources in the lungs of 
a realistic chest phantom which was corrected for the individual body 
builds of the volunteers (17, 18). 
Measurements were taken daily for one week and at intervals up to 
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seven weeks, 
Raw urine was counted in a calibrated geometry using the 100 KeV 
radiations detected by a shielded 3 in, x 3 in. NaI detector. Fecal 
samples were wet-ashed and reduced to a standard volume of 50 ml prior 
to counting on the same detector. The sampling period varied from total 
collection over the first few days to once per week at later times, 
Once the activity was below the limits of detection of the crystal, 
sampling was stopped. 
Results 
All results were decay corrected back to the time of inhalation 
and presented as comparing and contrasting the two subjects. 
Subject! 
Inhalation pattern 
Particle size 
. WeJgh~-
Height 
· Activity retained (Day 0) 
Subject g 
Inhalation pattern 
Particle size 
Weight -
Height 
Activity retained (Day 0) 
1 breath (4 liters)~hold 30 seconds 
0 • 1 }l1ll ( CMD) 
82 Kg 
178 cm 
122 nCi (total respiratory system) 
very shallow breathing at 250 ml--
total air breathed 10 liters 
O , 3 )l1ll ( CMD) 
80 Kg 
191 cm 
85 nCi (total respiratory system) 
The lung contents are shown on Figure 20, as derived from the 
calibrated thin crystal beneath the chest of the supine subject, all 
content being expressed as a percentage of the total initial deposit''o:f 
activity, The two curves demonstrate markedly the effects of change of 
breathing pattern. Case 1 is very similar to the retention pattern 
previously reported for the inhalation of Cr-51 labelled particles of 
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this size (0,1.)lm CMD) with a high retained fraction (90%) of a long 
half period of clearance (118 days) and a shorter-term clearance of 3,3 
days half period representing only 10% of the initial activity. All the 
initial deposited activity is seen in the trachea-bronchial (T-B) and 
pulmonary regions viewed by the detector, 
In Gase 2, when the shallow breathing pattern did not markedly 
exceed the inert gas deadspace, the maximum initial deposition was not 
in the field of view of the detector, i,e,, in the NP region, and only 
5,4% of the initially deposited activity appeared in the T-B/pulmonary 
regions, The statistics of counting this low percentage is such that 
the early clearance phase cannot be estimated and a long-term retention 
half period of 160 days is derived from this component; 
Figures 21 and 22 show the fecal and urinary excretion curves 
respectively, In Case 1, pulmonary deposition, 3,5% of the initial 
activity is cleared within the first eight days with a clearance period, 
after the peak of excretion at day 4, of 0,8 days, A long term excre-
tion period of 72 ± 30 days was also present with an amplitude of 
approximately 0,2% of the activity/day, A single exponential urinary 
clearance was seen in this case with a half period of 3,6 days and an 
initial amplitude of 0,19% of the initial activity, This half period 
of approximately 3,5 days seen both in the urinary excretion and in the 
lung clearance was also observed in the earlier Cr-51 inhalations, It 
represents the in vivo leaching of the small soluble plutonium fraction 
from the surface of the iron oxide aerosol and was studied in an ear1.. · 
lier chapter. 
In Case 2, deposition in upper respiratory tract and NP region, 
95% of the deposited activity was cleared within the first eight days 
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with a clearance period of 0,7 days after the peak on day 2, Urinary 
clearance was negligible only one sample (day 1) being above the limit 
of detection of the apparatus of 0,04% per day, The isotope account-
ability, i,e,, the sum of retained and excreted fractions, was good in 
both cases (90%)r Figure 23 shows the cumulative fractions retained and 
excreted together with the totals, 
Distribution of Activity 
The location of the inhaled activity within the thorax was attempt· 
ed using a collimated NaI crystal viewing the 100 KeV line, There was 
insufficient activity present to enable accurate assessment to be made 
without prohi bi ti vely long counting periods. Figure 24 shows rasul ts : 
of this exercise and the following broad conclusions can be made, 
For Case 1 the deposition (day 1) is fairly uniform throughout the 
lung initially, The counts are enhanced on day 2 by material moving 
I 
down the esophagus to the GI tract, After this time the plots show 
little deposition in the trachea and upper bronchii with long-retained 
material in the rest of the lung, The efficiency of detection of the 
200 KeV line is greater for the middle and upper region because of 
absorption in liver and other soft tissue of the lower lung gamma 
emissions, The increase in counts at the base of the lungs is probably 
significant and does represent enhanced deposition in this area. In 
Case 2, the initial deposition on day 1 is predominantly in the trachea 
and upper bronchii regions with rapid clearance of this material via the 
cilliated epithelium, the esophagus, and the GI tract, which explains 
the increase in counts over the lower thorax seen on day 2, The resid-
ual deposition was just above the limits of detection of the scanning 
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equipment and shows slight preferential deposition in the upper lung. 
Further wide location studies were made using the 5 in. diameter 
x 2 in, thick NaI crystal with a one inch steel collimation collar, The 
efficiency of this detector was higher than the slit collimator, but 
location could only be attempted to different quad.rants of the chest. 
In Case 1, the initial deposition was uniformly spread between the 
two lungs, within 10%, and after the first four days the longitudinal 
spread, base to apex, was also uniform to.within 10%, showing the breath-
ing pattern adopted had given uniform pulmonary deposition, Viewing 
the lungs from the back of the chest produced higher counting rates 
than viewing, in a similar geometry, the front of the chest, The 
magnitude of this effect was 40% and can partially be eXplained by the 
presence of the liver and the geometry of deposition and detection. 
This point is discussed more fully in conjunction with the detection of 
the L X-radiation (see following page). 
Similar measurements of the subject in Case 2 also produced a 
uniform distribution of residual activity after the clearance of the 
high initial deposition in the upper thorax, The counting rates from 
the residual activity from this subject were low, and poor counting 
statistics were obtained at times beyond four days, There was some 
evidence of slightly better detection performance with the detector 
placed below the chest rather than above, This point was more marked 
at the base of the lungs, probably due to absorption in the liver when 
the counter is positioned over the base of the right lung, 
Using the proportional counter, viewing the 17 KeV X-radiations in 
a similar way to obtain a crude d~stribution of deposited activity, 
Case 1 gave a fairly uniform response both above and below the chest 
80 
('t 15%) with peak activities seen above the upper chest and below the 
lower chest. This effect was again explained primarily by the distri-
bution of absorbing media being predominantly below the upper lung and 
above the lower lung. 
For Case 2 no significant activity was seen below the ehest in 
either position and the peak activity was seen in its upper lung (bifur-
oation of bronchii) with the counters placed above the chest. 
The Detection of the L X-radiations 
The raw counting data from the proportional counter measurements 
of the L X-radiations from Pu-237 were corrected for background; for 
contributions from the body gamma emitters, i,e,, Cs-137 and K-40; and 
for radioactive decay of Pu-2:37, In order to express the results as 
percentages of the initial intake and to compare them with the in vivo 
data derived from the scintillation detection of the higher energy lines 
from the inhaled Pu-237 together with the integrated fecal and urinary 
excretion, it was necessary to derive detection efficiency figures, 
At these low X-ray energies (13 to 21 KeV) such calibration figures are 
very dependent on the body build of the volunteer subjects and the sites 
of deposition of the iron oxide particles within the lung, Appreciable 
contributions to the counting rate in this X-ray band arise from the 
scattered and degraded gamma lines at 60 KeV and 100 KeV, These contri-
butions are again very dependent on the scattering medium, i,e., the 
body build of the subject, and on the choice of gas filling in the 
proportional counters. In order to get as much information as possible 
from the measurements, a range of gas fillings was used although a 
previous study had shown the optimum gas filling for the counters and 
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electronic system used consisted of a mixture of 66% xenon, 30% argon, 
and 4% methane (41). 
The initial calibration figures were obtained using the Winfrith 
chest phantom with a series of extended Pu-237 sources placed in the 
foam rubber lungs (18). These figures were then modified to allow for 
the gross differences in body build (chest structure) between the 
phantom and the subjects, A series of ultrasonic measurements of the 
soft tissue thickness overlying the ribs of a range of normal subjects 
had enabled the mean soft tissue thickness to be correlated with an 
expression involving the subject's height, weight, and chest circumfer-
ence only (17), Using such an expression, the me~ soft tissue thick-
nesses of Subjects 1 and 2 were 2 • .54 cm and 1.88 cm respectively, 
compared with 2,00 cm for the chest phantom. 
The derivation of this parameter applies only to the area of the 
chest normally viewed by the proportional counters when used for 
routine Pu-239 in vivo assay, i.e., that area from the third to the 
--
sixth rib inclusive, Considering the wide differences in particle 
deposition observed in these two subjects, the mean soft tissue thick-
ness correction as derived above was considered to be one of the first 
order only. Differences in calibration efficiency from those derived 
from the chest phantom would be a combination of geometxy ]differences · · 
of detection and differences in mean absorber thickness, 
Using the calibration efficiencies calculated from the chest 
phantom results, the observed data from the proportional counters were 
expressed as retained percentages of inhaled activity, and lung reten-
tion curves were drawn and compared to those obtained by scintillation· 
counting of the higher energy emissions (Figure 20), These are shown 
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on Figure 25 together with the scintillation deteotor results taken from 
Figure 20. In Case 2, the agreement between the 17 KeV detection and 
the 100 KeV detection was within the quoted errors (t 2 er) for all points 
and all gas fillings. The proportional c°-unter results gave a s~ple 
exponential least-squares-best-fit of 126-day ~lf period and 4,4% 
initial retained fraction, compared to that of 160 days and 5.4% obtain-
ed with the thin crystal. The errors in determining the half period 
were of the order of ! 2.5 days. All proportional oounter results were 
below the corresponding scintillation counter resultsr the mean ratio 
of matched pairs being 1.17 is within the errors of measurement. Alter-
natively this difference could be described as an error of 0.22 om in 
the ascribed mean soft tissue thickness (i,·e,, the same order as the 
standard error of the estimate 0,2 om): 
In the first inhalation (Case 1) there was no obvious agreement 
between the initial estimate of lung contents from the proportional 
counter measurements at 17 KeV and the scintillation counter results 
at 100 KeV, 
(: 
The two retention curves are also shown in Figure 25. Note 
also that there was no agreement between the results derived from differ-
ent gas fillings, The first three points (days 0-3) were obtained with 
a predominantly argon filling whioh is relatively insensitive to higher 
energy radiations and correspondingly more sensitive to errors in 
assumed mean soft tissue thicknesses, The later results were all ob-
tained with a composite gas filling of 50% argon and 50% xenon and gave 
good agreement between themselves, The results, as plotted on Figure 
25, can be modified by selecting a different mean soft tissue thickness 
from this subject, reflecting the observed distribution being predom-
inantly deep lung, Such an approach requires a knowledge of the 
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distribution of the different absorbing media, i,e,, lungs, muscle, fat 
liver,ltribs, 'etc., and the analysis would then correct counter resp®s'e 
at each energy for absorption, scattering, and geometry of detection, 
As a first approach a crude modification of the mean soft tissue 
factor was calculated, using the observed ratio of the counts obtained 
from the scintillation detection of the 100 KeV radiations from the 
front and back of the chest, The \Obs~rved ratio of 0,71 was then inter-
preted as both a geometry effect of distribution in the lungs and a cor-
responding increase in absorbing media above the base of the lungs, 
The total mean soft tissue thickness from such an approach was 4,0 cm 
compared with the earlier assumed figure of 2 • .54 om, The revised figure 
was realistic anatomically and in fairly good agreement with the work 
of Rundo et al,(42), Using such a factor t~e lung retention points 
were recalculated and are plotted on Figure ~6 together with the thin 
crystal (100 KeV) data as before. The anomaly between the results from 
the different gas fillings was no longer evident and the weighted-mean-
least-squares analyses of the two retention curves gave a composite 
curve, as shown of two components of 6 days and 200 days half period 
with amplitudes of 16% and 84% respectively. 
Dose to the Volunteers 
In both cases the doses to the lungs of the volunteers were cal-
culated taking the observed deposition patterns and known activity 
of alpha impurities, 
Case 1 total dose to lungs 180 mrem.s 
Case 2 total dose to lungs 13 mrems 
Of this dose 85% was due to the alpha impurities, The doses to 
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organs other than the lungs were negligible. 
Conolusions 
Although the low activity of the tagged particles in the lungs 
precluded accurate statistical analysis of the data, the retained lung 
fractions as derived from the detection of the gamma. radiations, gave 
results consistent with the earlier work with Cr-51 and with the I.C.R,P. 
Task G~oup on tung Dyna.mies(8). The method of approach again demonstra-
ted the feasibility of the technique of doing lung retention studies 
using minimal amounts of aerosol and activity. 
The extrapolation of the data from the detection of the 17 KeV 
X-radiation to the problem of the detection of Pu-239 ,!u vivo reV'ealed'~ 
that, although the difficulties of low level detection of these radia-
tions is to a large extent overcome, the interpretation of the results 
in terms of retained lung burdens still posed problems. The approach 
of using realistio chest phantoms to supply the basic oalibration data. 
and attempting to modify such data by body build parameters would appear 
still to be a valid method but obviously one of first-order oo.;r:rection 
only, Without such corrections, e:t'rors of up to a factor of 10 in 
calibration would ooour. 
With the two extremes of breathing pattern chosen for this study 
the observed errors (using the body build correction factor) were 1.17 
and 2.0 for the two cases (note that the error was 4.0 for Case 1 using 
t) 
a gas filling of argon/methane only), In both cases the lung burden of 
plutonium would have been undefe~timated, Without some knowledge of 
the distribution in the lung (i,e,, particle size, breathing pattern, 
length of exposure) following an actual incident, the only check on 
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validity of the choice of calibration factor would be serial fecal col-
lection to follow observed lung clearance. At low levels of internal 
contamination when the subject is still working in a plutonium labora-
tory and probably handling a range of plutonium fuels, such an approach 
becomes of doubtful validity even if serial fecal sampling were accep-
table on other grounds and accurate low-level analysis could be per-
formed, 
Although there is little doubt that in an accidental inhalation 
the particle size distribution and breathing pattern of Case 1 would 
not be encountered and that the normal in vivo counting procedures in 
these laboratories would produce an estimate of within 50% of the tissue 
lung contents even in the case of an atypical exposure, further studies 
on detection following normal breathing patterns are desirable, A pro-
gram of work has now been started using more accurate anatomical models 
to predict the response of the detectors to various distributions of 
Pu-239 in the lung and to study the feasibility of alternative placing 
of the detectors around the chest or the use of multi-detector arrays 
to reduce the uncertainties produced by anomalous distributions of 
particles within the lung. 
CHAPTER VII 
CONCLUSIONS AND RECOMMENDATIONS 
Because all radiological limits are based on the dose-effect rela-
tionship for the irradiation of biological systems, one of the prime 
considerations in evaluating the potential hazards from internally de-
posited radioisotopes is the biological dose received by various organs. 
In suoh a determination the accurate estimation of the activity intake, 
A, is of paramount importance. Since reconstruction of acute intake is 
0 
not often possible, the only alternative solution to the problem is the 
estimation of A0 after the fact by any measure available. 
The measures which are available would be better if it were not 
for the fact that each inhalation and each victim is physically and 
physiologically different. What is needed, therefore, is a set of data 
correction factors involving physical and physiological variables. The 
raw counting or bioassay data could th~n be treated with the factors to 
yield an estimate of A. Previous attempts have been made to achieve 
0 
this goal, but the results are limited because of the restriction of 
related research to laboratory animals or to human phantom studies. 
Following an analysis of calibration errors which exist in phantom-
related work, an experiment was proposed to minimize these errors. A 
limited number of experiments were proposed using human volunteers 
inhaling an aerosol of known activity, solubility, and particle size, 
Data from the volunteers were to be collected over a definite period of 
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time by enough independent means to indicate both levels and trends 
concerning aerosol retention, excretion, translocation, and distribution, 
It was decided that the most efficient implementation of these ob-
jectives would necessitates (a) development, construction, and testing 
of a suitable aerosol generating apparatus, (b) production and investi-
gation of properties of a suitable aerosols (c) sequential inhalations 
by a single volunteer of an aerosol tagged first with a soluble form of 
a gamma.,1emitting isotope and then with an insoluble form of the same 
isotope with subsequent compilation of data on the retention, excretion, 
and distribution of the inhaled materialJ and (d) inhalations by two 
volunteers of an aerosol tagged with the insoluble form of an isotope 
which emits both X-rays in the 13-22 KeV region and gamma rays in the 
100-400 KeV region. In these latter inhalations, one volunteer would 
use a one-deep-breath-and-hold breathing pattern while the other volun-
teer would use shallow, continuous breathing with the same data being 
taken as in the previously mentioned inhalations, 
Conclusions 
Some conclusions which can be drawn from these experiments area 
1. Sub-micron particles generated by ultrasonic nebulization are 
. 
hollow and have widely varying densities depending upon their size, 
2. Excretion, retention, and distribution results following the 
inhalation of particles generated by ultrasonic nebulization are eon-
sistent with ICRP Lung Dynamics Task Group models, 
3, The rates and magnitudes of very early lung clearance are 
independent of the solubility of the inhaled material, 
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4. Excretion, retention, and distribution characteristics of both 
soluble and insoluble aerosols can be shown to be identical when the 
appropriate leaching factors are applied to the data. 
5. The inhalation breathing pattern is the primary variable affect-
ing the depth of deposition. 
6. The approach of using realistic chest phantoms to supply the 
basic calibration data and of attempting to modify such data by body-
build parameters appears to be a valid method but one of first-order 
correction only. 
?. Without any phantom calibration correction, errors up to a 
factor of 10 may occur, 
Recommendations for Further Work 
The collection, analysis, and discussion of these experiments have 
revealed several worthwhile extensions of this work. This further work 
might includes 
The correlation1of these ~an inhalation calibrations with cali-
brations of realistic chest phantoms which are in existence, 
The extension of phantom work to more accurate anatomical models. 
The modification of the inhalation apparatus to make inhalation 
procedures more automatic, 
The extension of the correlation between in vitro leaching and 
excretion to actual plutonium processing materials, 
The investigation of depositions resulting from breathing patterns 
more nearly normal than the ones used in these experiments. 
The investigation of a much greater range of particle sizes and 
particle solubilities. 
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The use of the inhalation techniques developed here in the clinical 
diagnosis of pulmonary disorders, 
The improvement of scanning results by using multiple:placement 
of detectorsp multidetector arrays, or clinical scanners. 
The utili~ation of more complicated particle shapes in similar 
investigations. 
The multi-isotope scanning of lungs which have inhaled several 
particle sizes each labeled with unique isotopes, 
These recommended extensions would accomplish two very desirable 
goals, They would apply the knowledge gained to problems existing out-
side the laboratory and they would extend the knowledge gained to encom-
pass parameters which are more realistic within the laboratory. 
( 1) 
( 2) 
( 3) 
( 4) 
( .5) 
( 6) 
( 7) 
( 8) 
( 9) 
(10) 
(11) 
SELECTED BIBLIOGRAPHY 
Cochran, Terence H, et al, "Liver Injury 1n Beagles with Pu-2391 
Distribution Dosage and Damage," Health Physics Journalp 
Vol, 8 (1962), 699-703, 
Stover, B, J, et al, "Further Studies of the Metabolism of Pu-239 
in Adult Beagles," Health Physics Journalp Vol, 8 (1962)p 
.589-.597, 
Dougherty, T, F, et al, "Studies of the Biological Effects of 
Ra-226, Pu-239, Ra-228, Th-228 and Sr-90 in Adult Beagles," 
Radiation Research, Vol, 17 (1962), 62.5-682, 
Scottp K, G, et al, "Deposition and Fate of Plutoniump Uraniump 
and Fission Products Inhaled As Aerosols," Archives of 
Pathology, Vol, 48 (July 1949)P 31-.54, ~ 
Abramsp et al, "Metabolism and Distribution of Inhaled Pu in 
Rats," University of Chicago Metallurgical Laboratory Report 
CH-36.5.5, 
Bairp W. J, et al, "Retention, Translocation and Excretion of 
Inhaled Pu-239 o2." Health Physics Journal, Vol, 8 (1962)P 
639-649, 
Langham, W, H, et al. "The Los Alamos Scientific Laboratory's 
Experience with Plutonium in Man," Health Physics Journalp 
Vol, 8 (1962), 7.53-760, 
Task Group on Lung Dynamics, "Deposition and Retention Models 
for Internal Dosimetry of the Human Respiratory Tract, 11 
Health Physics Journal, Vol, 12 (1966), 173-207, 
Hounam, R, F,p A, Black, and M, Walsh, "The Deposition of 
Aerosol Particles in the Nasopharyngeal Region of the Human 
Respiratory Tract," U, K, Atomic Energy Establishment Report, 
Harwell, AERE--R .5860, (1970), 
Waite 0 D, A. and B, V, Anderson, "A Projection Chest Phantom for 
In Vivo Dosimetry," American Industrial Hygiene Association 
Journal'0 Vol, 31 (May-June 1970), 322-326. 
Dautrebande L, and W, Walkenhorst, "Deposition of Microaerosols 
in Human Lung with Special Reference to the Alveolar Spaces, 11 
Health Physics Journal, Vol, 10 (1964), 981-993, 
93 
(12) Rhodes, B, A. et al, "Radioactive Albumin Microspheres for 
Studies of Pulmonary Circulation," Radiology, Vol, 92 (1969) 0 
14.53. 
(13) Black, A, and M, Walsh, "Production of Uniform Radioactive 
Particles for Aerosol Inhalation Experiments--Part I. 
Particles in the Size Range 1-10 u," U, K, Atomic Energy 
Establishment Report, Harwell, AERE--R .5716 (1968), 
(14) Directory of Whole Body Radioactivity Monitors--12.ZQ. Edition, 
Viennas International Atomic Energy Agency, 1970, 
(1.5) Peabody, C, O,, v. M, Fraser, and R, G, Speight, "The A, E, E, 0 
Winfrith 0 Whole Body Monitor," U, K, Atomic Ener~y 
Establishment Report, W1nfr1th, AEEW--R 21.5 (1962), 
(16) Ramsden, D, "A Multiwire Proportional Counter for the Detection 
of Pu-239 In Vivo,'' U. K. Atomic Energy Establishment 
Report, Winfrith, AElilW--M .526 (196.5), 
(17) Ramdsen, D,, R. T. Speight, and C, 0, Peabody, "The Use of 
Ultrasonics to Investigate Soft Tissue Thickness on the 
Human Chest," U, K, Atomic Energy Establishment Report, 
Winfrith, AEEW--R 493 (1967), 
(18) Speight, R, G,, G, 0, Peabody, andD, Ramsden, "An Improved 
Chest Phantom for Studies of Plutonium and Americium in Human 
Lungs," Assessment of Radioactivity in Man, Vol, 1. Viennag 
International Atomic Energy Agency, 1964, 11.5, 
(19) Ramsden 0 D, and R. E, Davis. "Unpublished work". 
(20) 
(21) 
(22) 
(23) 
(24) 
Park0 J, F~, et al, U. S, Atomic Energy Commission Report, 
Battelle, BNWL--10.50 (1970), 
Davies 0 C, N., Editor. Proceedings .2f Second International 
Symposium on Inhaled Particles and Vapors. New Yorks 
Pergamon Press, 1967, 
Lippmann, M. and R, E, Albert, "The Effect of Particle Size on 
the Regional Deposition of Inhaled Aerosols in the Human 
Respiratory Tract," American Industrial Hygiene Association 
Journal, Vol, 30 (1969), 247-275, 
Hanna, M, G, 0 Jr,, P. Nettesheim, and J, R. Gilbert, Editors, 
Inhalation Carcinogenesis. USAEC Division of Technical 
Information, 1970, 
Ramsden D, "The Measurements of Plutonium-239 In Vivo," Health 
Physics Journal, Vol, 16 (1969), 14.5-1.54, ~ ~ 
(2.5) Ramsden 0 D,, M, E, D, Bains, and D, G, Fraser, "In Vivo and 
Bioassay Results from Two Contrasting Cases of Plutonium-239 
Inhalation. " Heal th Physics Journal, Vol 19 ( 1970) , 9-17, 
(26) Kanapilly, G, M,, o. G, Raabe and G, J, Newton, ''A New Method for 
Generation of Aerosols of Insoluble Particles for Use in 
Inhalation Studies," Journal of Aerosol Science, Vol, 1 
(1970), 313. ~ 
(27) Albert 0 R, E, et al. "Fabrication of Monodisperse Lucite and Iron 
Oxide Particles with a Spinni~ Disk Generator," Health 
Physics Journal, Vol, 10 (1964), 933-940, 
(28) Herzog, P,, 0, P. Norlander, and C, G, Engstrom, "Ultrasonic 
Generation of Aerosol for the Humidification of Inspired Gas 
During Volume Controlled Ventilation," Acta Anaesthesiologica 
Scandinavica, Vol, 8 (1964), 79-9.5. 
(29) Metnieks, A. L, and L, W, Pollak. •'I Instruction for Use of 
Photoelectric Condensation Nucleus Counters," Geophysical 
Bulletin, No, 16, School of Cosmic Physics, Dublin Institute 
for Advanced Studies, (19.59). 
(30) Albertp R, E, "Personal communication," 
(31) Waite, D, A. and D, Ramsden. "The Production of Experimentally 
Labelled Aerosols in the Sub-Micron Range," Journal of 
Aerosol Science, in press, 
(32) Brown, C, E, Inhaled Particles and Vapors. New Yorkg Pergamon 
Pressp 1961. 
(33) 
(34) 
(35) 
(36) 
(37) 
(38) 
Waite, D, A, and D, Ramsden, ''The Inhalation of Insoluble Iron 
Oxide Particles in the Sub-Micron Range--Chromium-.51 Labelled 
Aerosols," U, K, Atomic Energy Establishment Report, Winfrith, 
AEEW--R 740 (1971). 
Morueci, J, P, Commisariat a l•Energie Atomique Report, CEAR--
3027 (1966). 
Taylor, B, T, "A Proportional Counter for Low-Level Measurement 
of Plutonium-239 in Lungs," Health Physics Journal, Vol 17 
(1969), .59-69, 
Laurerp G, and E, Eisenbud, ~Diagnosis and Treatment of Deposited 
Radionuclides," ExcerRta Medica (1968), 189, 
Tomitani, T. and E, Tanaka, "Large Area Proportional Counter for 
Assessment of Plutonium Lung Burden," Health Physics Journal, 
Vol, 18 (1970), 19.5-206, 
Swinth, K, L, "Diagnosis and Treatment of Deposited 
Radionuclides," Excerpta Medica (1968), 208, 
(39) 
9.5 
Rundo, J. et al. "Attenuation in the Chest Wall of 20 KeV X-rays 
from a.n Inhaled Radioactive Aerosol." · Nature, Vol, 217 
(1968), 642-643. 
(40) Todd0 R, and R. Logan, "Plutonium-237 for Metabolic Studiesa Its 
Preparation and Use." International Journal of Applied 
Radiation and Isotopes, Vol, 19 (1968), 141-14.5, 
(41) 
(42) 
Pike, R. A. and D. Ramsden. U, K, Atomic Energy Establishment 
Report, Winf'rith, AEEW--M 912 (1969). 
Rundo, J., K. R. Rudran, and B. T, Taylor. "Effective Tissue 
Thickness for External Counting of Low Energy Emitters in 
Lung." Health Physics Journal, Vol, 17 (1969), 1.5.5-157, 
V.ITA. 
David Alan Waite 
Candidate for the Degree of 
Dootor of Philosophy 
Thesis& THE PRODUCTION AND HUMAN INHALATION OF PLUTONIUM LABlllLLlllD 
PARTICLES IN THE SUB-MICRON RANGE 
Major Fields General Engineering 
Biographical a 
Personal Dataa Born in El Dorado, Kansas, June 25, 1941, the son 
of Mr, and Mrs, Noble V, Waite, Married to Nancy Dillingha11 
on August 26, 1962 and father of two sons, 
Education, Graduated from El Dorado High School, El Dorado, Kansas, 
in May, 19591 attended University of Kansas in 1959-19601 
received Bachelor of Arts degree from Kansas State Teachers 
College in 1963 with a major in Physics, received Master of 
Soienoe degree from Vanderbilt University in 1965 on a 
Physical Biology Training Grant, completed requirements for 
the Doctor of Philosophy degree at Oklahoma State University 
in May, 1972, 
Professional Experience, Asst, Prof, and Head, Department of 
Radiation and Nuclear Technology, Oklahoma State University, 
1965-701 Summer Scientist, J3attelle Northwest Laboratory, 
Summers of 1967-681 Attached Staff, Radiological and Safety. 
Division, Atomic Energy Establishment, Winfrith, Dorset, 
England, 1970-71s President and Chief Consultant, Radiation 
Services and Consultants, Inc,, October 1968 to present, 
Professional Organi21ations1 Sigma Pi Sigma, Lambda Delta Lambda, 
Health Physics Society, Society of Nuclear Medicine 
